Emergent BioSolutions to Participate in Investor Conferences

Rhea-AI Summary

Emergent BioSolutions will participate in key investor conferences in June 2022, including:

• Benchmark Healthcare House Call Virtual 1X1 Conference on June 2.
• NYSE Healthcare & Technology Virtual Investor Access Day on June 8.
• East Coast IDEAS Conference on June 22, featuring a pre-recorded presentation accessible at 6:00 am ET.

Webcast presentations may discuss business developments and financial results, available live and on replay via the Emergent website.

GAITHERSBURG, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences:

• Benchmark Healthcare House Call Virtual 1X1 Conference
  June 2, 2022
  

• NYSE Healthcare & Technology Virtual Investor Access Day
  June 8, 2022

• East Coast IDEAS Conference
  June 22, 2022
  Pre-recorded presentation will be accessible beginning at 6:00 am ET
  https://wsw.com/webcast/threepa37/ebs/

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 20 years, we’ve been at work defending people from things we hope will never happen—so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Matt Hartwig
Senior Director, Media Relations
mediarelations@ebsi.com

FAQ

What investor conferences will Emergent BioSolutions participate in June 2022?

Emergent BioSolutions will participate in three conferences: Benchmark Healthcare House Call on June 2, NYSE Healthcare & Technology on June 8, and East Coast IDEAS Conference on June 22.

Where can I watch Emergent BioSolutions' presentations during the investor conferences?

Emergent BioSolutions' presentations will be available live and via replay on the Emergent website.

What date is the East Coast IDEAS Conference for Emergent BioSolutions?

The East Coast IDEAS Conference is scheduled for June 22, 2022.

Will Emergent BioSolutions discuss financial results at the conferences?

Yes, Emergent BioSolutions may discuss recent business developments and financial results during the conference presentations.

How can I access the pre-recorded presentation of Emergent BioSolutions?

The pre-recorded presentation for the East Coast IDEAS Conference will be accessible starting at 6:00 am ET on June 22, 2022.